The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia

Update Il y a 4 ans
Reference: NCT01101295

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary purpose of the study is to describe by a prospective observational study the serious adverse events occurring in patients treated off-label by rituximab for Immune Thrombocytopenia.


Inclusion criteria

  • Purpura, Thrombocytopenic, Idiopathic ,Autoimmune Thrombocytopenia

Links